Stocks IZM Financial statements
Financial statementsICZOOM Group Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data ICZOOM Group Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | 290 | 214 | 178 | 187 | |
| Cost of revenue | 283 | 209 | 173 | 181 | |
| Gross profit | 7.81 | 5.29 | 4.95 | 6.11 | |
| General and administrative | 2.51 | 2.43 | 3.95 | 2.96 | |
| Operating expenses | 4.44 | 4.42 | 6.29 | 5.13 | |
| Operating income | 3.37 | 0.88 | -1.34 | 0.98 | |
| Interest expense | 0.36 | 0.57 | 0.7 | 0.4 | |
| Interest income | 0.03 | 0.01 | 0.07 | 0.14 | |
| Other non-operating income | -0.21 | 1.14 | -0.99 | 0.51 | |
| Pre-tax income | 3.16 | 2.02 | -2.34 | 1.49 | |
| Income tax | 0.59 | 0.27 | -0.07 | 0.3 | |
| Net income | -0.22 | 2.57 | 1.75 | -2.27 | 1.19 |
| EBITDA | 3.52 | 1.07 | -1.09 | 1.19 | |
| EPS, basic | 0.29 | 0.19 | -0.22 | 0.10 | |
| EPS, diluted | 0.27 | 0.18 | -0.20 | 0.10 | |
| Shares, basic (weighted) | 8.83 | 9.2 | 10.4 | 11.6 | |
| Shares, diluted (weighted) | 9.55 | 9.92 | 11.1 | 11.6 |
Balance sheet
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash and equivalents | 6.81 | 2.95 | 6.41 | 5.48 | 8.38 |
| Short-term investments | 0.93 | 0 | |||
| Receivables | 76 | 76.7 | 28.3 | 27.2 | |
| Inventory | 0.37 | 0.83 | 0.34 | 1.33 | |
| Other current assets | 2.43 | 1.34 | 0.98 | 1.52 | |
| Total current assets | 88.4 | 86.9 | 39.1 | 40.2 | |
| Property, plant and equipment | 0.12 | 0.13 | 0.12 | 0.06 | |
| Lease right-of-use assets | 0.69 | 0.86 | 0.38 | 0.82 | |
| Intangible assets | 0.38 | 0.29 | 0.2 | 0.13 | |
| Other non-current assets | 0.01 | 0.01 | 0 | 0.01 | |
| Total assets | 89.6 | 88.2 | 40 | 41.2 | |
| Accounts payable | 59.6 | 51.1 | 5.26 | 4.28 | |
| Deferred revenue | 3.65 | 1.67 | 3.04 | 2.22 | |
| Short-term debt | 11.8 | 14 | 10.2 | ||
| Total current liabilities | 78.7 | 72.3 | 24.6 | 25.4 | |
| Lease liabilities | 0.48 | 0.38 | 0.44 | ||
| Total liabilities | 79.1 | 72.6 | 24.6 | 25.8 | |
| Paid-in capital | 14.5 | 18.8 | 20 | 20.5 | |
| Retained earnings | -7.09 | -5.33 | -7.61 | -6.41 | |
| Other comprehensive income | 1.04 | -0.19 | 0.65 | -1.23 | |
| Shareholders' equity | 7.41 | 10.5 | 15.5 | 15.4 | 15.4 |
| Total equity | 7.41 | 10.5 | 15.5 | 15.4 | 15.4 |
| Total liabilities and equity | 89.6 | 88.2 | 40 | 41.2 | |
| Shares outstanding | 8.83 | 10.3 | 11 |
Cash flow statement
| FY2021 | FY2023 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | -0.22 | 2.57 | 2 | -2.27 | 1.19 |
| Depreciation and amortization | 0.15 | 0.2 | 0.26 | 0.21 | |
| Stock-based compensation | 0.05 | 1.33 | 1.16 | 0.61 | |
| Deferred income tax | 0.01 | 0.02 | -0.13 | 0.13 | |
| Change in receivables | -9.21 | -3.71 | 49.5 | 1.21 | |
| Change in inventory | 2.1 | -0.5 | 0.51 | -0.99 | |
| Change in payables | 5.18 | -6.36 | -46.4 | -0.99 | |
| Cash from operations | -0 | 0.14 | -3.75 | 2.08 | 2.75 |
| Capital expenditures | -0.02 | -0.08 | -0.1 | -0.03 | |
| Purchases of investments | -20 | -4.13 | -1.12 | -4.05 | |
| Cash from investing | 0.86 | -0.14 | -0.16 | -0.08 | |
| Stock issued | 4.43 | 1.27 | 0.11 | ||
| Cash from financing | -3.5 | 8.75 | -2.25 | 2.91 | |
| Exchange rate effect | 0 | -1.36 | -1.39 | -0.61 | -2.69 |
| Net change in cash | -0 | -3.86 | 3.46 | -0.93 | 2.89 |
| Free cash flow | 0.12 | -3.83 | 1.98 | 2.71 | |
| Interest paid | 0.36 | 0.57 | 0.7 | 0.4 | |
| Income taxes paid | 0.15 | 0.19 | 0.15 | 0.1 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 3.3% | Gross profit / revenue. |
| Operating margin | 0.5% | Operating income / revenue. |
| EBITDA margin | 0.6% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 0.8% | Pre-tax income / revenue. |
| Net margin | 0.6% | Net income / revenue. |
| FCF margin | 1.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 1.5% | Cash from operations / revenue. |
| Effective tax rate | 20.0% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 7.8% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 2.9% | Net income / average total assets. |
| Return on invested capital (ROIC) | 9.3% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Stock-based pay / revenue | 0.3% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.0% | Capital expenditures / revenue. |
| D&A / revenue | 0.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 5.1% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -13.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 23.4% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -7.9% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 3y | -33.7% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 3y | -30.3% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 3y | -22.5% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 3y | -28.2% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 31.9% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 170.6% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 36.7% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 185.7% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 0.3% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 13.7% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 3.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -22.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 4.2% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 6.6% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.58x | Current assets / current liabilities. |
| Quick ratio | 1.40x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.33x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 62.6% | Total liabilities / total assets. |
| Interest coverage | 2.48x | Operating income / interest expense. |
| Working capital | $14.8M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $15.3M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 4.61x | Revenue / average total assets. |
| Fixed asset turnover | 2,068x | Revenue / average property, plant and equipment. |
| Inventory turnover | 217x | Cost of revenue / average inventory. |
| Days inventory | 2 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 6.74x | Revenue / average receivables. |
| Days sales outstanding | 54 days | 365 x average receivables / revenue. |
| Days payables | 10 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 46 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 227.2% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 1.2% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.10 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.10 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $16.19 | Revenue / diluted weighted shares. |
| FCF per share | $0.23 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.24 | Cash from operations / diluted weighted shares. |
| Book value per share | $1.33 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.32 | Tangible book value / shares outstanding. |
| Cash per share | $0.73 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $15.5M | Share price x shares outstanding. |
| Enterprise value | $7.1M | Market cap + total debt - cash - short-term investments. |
| P/E | 13.0x | Market cap / net income. Only when net income is positive. |
| P/S | 0.08x | Market cap / revenue. |
| P/B | 1.01x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.01x | Market cap / tangible book value, when positive. |
| P/FCF | 5.71x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 5.65x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.04x | Enterprise value / revenue. |
| EV/EBIT | 7.24x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 5.98x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 2.62x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 17.5% | Free cash flow / market cap. |
| Earnings yield | 7.7% | Net income / market cap (the inverse of P/E). |
What was ICZOOM Group Inc.'s revenue in fiscal 2025?
ICZOOM Group Inc. reported revenue of $187.0M for fiscal 2025, 5.1% higher than the year before.
Was ICZOOM Group Inc. profitable in fiscal 2025?
Yes. Net income was $1.2M, a net margin of 0.6%.
How much free cash flow did ICZOOM Group Inc. generate in fiscal 2025?
Cash from operations of $2.7M minus capital expenditures of $32.5K left free cash flow of $2.7M.